American Journal of Epidemiology Vol. 136, No. 3: 287-295
Copyright © 1992 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Allergy and Cancer: Organ Site-Specific Results from the Adventist Health Study
From the Department of Public Health and Preventive Medicine, Loma Linda University Loma Linda, CA
Reprint requests to Dr. Paul K. Mills, Department of Public Health and Preventive Medicine, Evans Hall 204, Loma Linda University, Loma Linda, CA 92354.
The relation between allergy and risk of cancer was evaluated in a cohort study of 34, 198 Seventh-day Adventists in California. Information on prevalence of asthma, hay fever, and reactions to chemicals, medications, bee stings, and poison oak (or ivy) was obtained by questionnaire in 1976. The reported allergies must have been serious enough to require treatment by a physician. The cohort was then followed for 6 years (1977–1982). Both stratified analysis and Cox proportional hazards regression analyses were utilized to evaluate the relation of allergy to cancer after taking into account several potentially confounding variables. For all cancer sites combined in males, there was a 33% increased risk associated with reaction to medications. In contrast, among females, reaction to medications was associated with a 21% decrease in risk. Both results were statistically significant. Prostate and breast cancer risk were elevated in persons who reported any type of allergic history, as was risk of lymphatic or hematopoietic cancers and sarcoma. For each of these types of cancer, risk increased with increasing numbers of allergies. However, ovarian cancer risk was decreased in persons with any allergic history and increasing numbers of allergies was associated with decreasing risk of this form of cancer. These results suggest that the association between allergy and cancer is complex and depends on the specific allergy and the specific organ site under consideration. Am J Epidemiol 1992; 136: 287–95.
allergens; allergy; neoplasms; risk
*Deceased
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. A. Nigro, A. T. Brini, E. Soprana, A. Ambrosi, D. Dombrowicz, A. G. Siccardi, and L. Vangelista Antitumor IgE Adjuvanticity: Key Role of Fc{epsilon}RI J. Immunol., October 1, 2009; 183(7): 4530 - 4536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Vajdic, M. O. Falster, S. de Sanjose, O. Martinez-Maza, N. Becker, P. M. Bracci, M. Melbye, K. E. Smedby, E. A. Engels, J. Turner, et al. Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis Cancer Res., August 15, 2009; 69(16): 6482 - 6489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Prizment, A. R. Folsom, J. R. Cerhan, A. Flood, J. A. Ross, and K. E. Anderson History of Allergy and Reduced Incidence of Colorectal Cancer, Iowa Women's Health Study Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2357 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Buhl Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy Eur. Respir. Rev., September 1, 2007; 16(104): 73 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Karagiannis, M. G. Bracher, J. Hunt, N. McCloskey, R. L. Beavil, A. J. Beavil, D. J. Fear, R. G. Thompson, N. East, F. Burke, et al. IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells J. Immunol., September 1, 2007; 179(5): 2832 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ellison-Loschmann, Y. Benavente, J. Douwes, E. Buendia, R. Font, T. Alvaro, M. Kogevinas, and S. de Sanjose Immunoglobulin E Levels and Risk of Lymphoma in a Case-Control Study in Spain Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1492 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Turner, Y. Chen, D. Krewski, P. Ghadirian, M. J. Thun, and E. E. Calle TURNER ET AL. REPLY Am. J. Epidemiol., February 15, 2006; 163(4): 395 - 396. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hagstromer, W. Ye, O. Nyren, and L. Emtestam Incidence of Cancer Among Patients With Atopic Dermatitis Arch Dermatol, September 1, 2005; 141(9): 1123 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gandini, A. B. Lowenfels, E. M. Jaffee, T. D. Armstrong, and P. Maisonneuve Allergies and the Risk of Pancreatic Cancer: A Meta-analysis with Review of Epidemiology and Biological Mechanisms Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1908 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Turner, Y. Chen, D. Krewski, P. Ghadirian, M. J. Thun, and E. E. Calle Cancer Mortality among US Men and Women with Asthma and Hay Fever Am. J. Epidemiol., August 1, 2005; 162(3): 212 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Talbot-Smith, L. Fritschi, M. L. Divitini, D. F. J. Mallon, and M. W. Knuiman Allergy, Atopy, and Cancer: A Prospective Study of the 1981 Busselton Cohort Am. J. Epidemiol., April 1, 2003; 157(7): 606 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Briggs, R. S. Levine, and E. A. Brann Allergies and Risk of Non-Hodgkin's Lymphoma by Subtype Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 401 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boffetta, W. Ye, G. Boman, and O. Nyren Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden Eur. Respir. J., January 1, 2002; 19(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. McDuffie, P. Pahwa, J. R. McLaughlin, J. J. Spinelli, S. Fincham, J. A. Dosman, D. Robson, L. F. Skinnider, and N. W. Choi Non-Hodgkin's Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1155 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Reali, J. W. Greiner, A. Corti, H. J. Gould, F. Bottazzoli, G. Paganelli, J. Schlom, and A. G. Siccardi IgEs Targeted on Tumor Cells: Therapeutic Activity and Potential in the Design of Tumor Vaccines Cancer Res., July 1, 2001; 61(14): 5517 - 5522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis, February 1, 2001; 22(2): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vineis, P. Crosignani, C. Sacerdote, A. Fontana, G. Masala, L. Miligi, O. Nanni, V. Ramazzotti, S. Rodella, E. Stagnaro, et al. Haematopoietic cancer and medical history: a multicentre case control study J Epidemiol Community Health, June 1, 2000; 54(6): 431 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Williams, E. M. Stone, B. C. Millar, A. Hewer, and D. H. Phillips Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts Mutagenesis, March 1, 2000; 15(2): 149 - 154. [Abstract] [Full Text] [PDF]
|
|